Bradley Foster & Sargent Inc Clear Point Neuro, Inc. Transaction History
Bradley Foster & Sargent Inc
- $5.77 Billion
- Q4 2024
A detailed history of Bradley Foster & Sargent Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 56,663 shares of CLPT stock, worth $989,335. This represents 0.02% of its overall portfolio holdings.
Number of Shares
56,663Holding current value
$989,335% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.8MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$21.7 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$8.1 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$6.54 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$6.4 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.82 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $428M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...